ClearPoint Neuro
CLPT
89 hedge funds and large institutions have $117M invested in ClearPoint Neuro in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 11 closing their positions.
1,361% more call options, than puts
Call options by funds: $7.09M | Put options by funds: $485K
100% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 11
53% more capital invested
Capital invested by funds: $76.5M → $117M (+$40.5M)
33% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 18
14% more funds holding
Funds holding: 78 → 89 (+11)
2.84% more ownership
Funds ownership: 24.73% → 27.56% (+2.8%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.64M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$3.21M |
| 3 |
Jane Street
New York
|
+$1.57M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.43M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$3.42M |
| 2 |
TFCM
Taylor Frigon Capital Management
Scottsdale,
Arizona
|
-$2.11M |
| 3 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$841K |
| 4 |
Citigroup
New York
|
-$810K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$787K |
CLPT Hedge Fund Activity: Q4 2024 in Review
89 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q4 2024, worth a combined $117M — up 53% from $76.5M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new CLPT positions and 11 closed out — a net gain of 11 holders — while 24 added to existing stakes and 18 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $4.64M. The largest seller was Marshall Wace, cutting an estimated $3.42M.
- 89 institutional investors held ClearPoint Neuro (CLPT) as of Q4 2024, up from 78 in Q3 2024.
- Funds reported $117M of ClearPoint Neuro stock for Q4 2024, up 53% quarter-over-quarter.
- 22 funds opened new ClearPoint Neuro positions in Q4 2024 and 11 closed out, a net change of +11 holders.
- The largest ClearPoint Neuro buyer in Q4 2024 was Susquehanna International Group, an estimated $4.64M added.
- The largest ClearPoint Neuro seller in Q4 2024 was Marshall Wace, an estimated $3.42M sold.
Based on aggregated 13F filings for Q4 2024.